Oxford researchers started new trial on the use of anti-TNF to treat Covid-19 in care homes
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
On Sept. 29, 2020, the National Institute of Allergy and Infectious Diseases announced that a phase 1 trial…
On Sept. 29, 2020, CureVac announced that the first participant has been dosed in a Phase 2a clinical…
On Sept. 29, 2020, the CDC reported that during Aug. 2ヨSept. 5, 2020, weekly COVID-19 cases among persons…
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
On Sept. 29, 2020, Moderna announced the publication of the second interim analysis of the open-label Phase 1…
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
On Sept. 28, 2020, the World Health Organization announced agreements to make available, for low and middle-income countries,…
On Sept. 28, 2020, Eiger BioPharmaceuticals announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in…
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
On Sept. 28, 2020, Hologic announced that its Panther Fusionᆴ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, OpGen announced the successful completion of the clinical study between its subsidiary, Curetis, and…
On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
On Sept. 28, 2020, INOVIO announced the U.S. Food and Drug Administration (FDA) had notified the company that…
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
On Sept. 24, 2020, new findings reported by scientists at the National Institutes of Health and their collaborators…
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
On Sept. 24, 2020, Novavax announced that it had initiated its first Phase 3 study to evaluate the…
On Sept. 23, 2020, a fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019…
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…